发明名称 Kombinerade doser av formoterol och ett antikolinergiskt medel
摘要 Metered dry powder combined doses (100) of finely divided dry medication powders are administered by selecting first and second medicaments for forming of pharmaceutical, combined doses. The first medicament comprises pharmaceutically acceptable salt, enantiomer and/or racemate. The second medicament comprises salt, enantiomer, racemate, hydrate and/or solvate. - Administration of metered dry powder combined doses of finely divided dry medication powders by a dry powder inhaler involves selecting first and second medicaments for forming of pharmaceutical, combined doses, where the first medicament comprises pharmaceutically acceptable salt, enantiomer and/or racemate, and the second medicament comprises for salt, enantiomer, racemate, hydrate and/or solvate, where first and second medicaments may include excipients; preparing metered dry powder medicinal combined doses having separately deposited entities (1-3) of medicinally quantities of each of the medicaments onto selected target areas of a common dose bed (20), where the sum of the deposited entities constitutes powder of the medicinal combined doses; introducing the combined doses into an inhaler device adapted for a prolonged dose delivery and when suction is applied through the inhaler, the powders of the combined doses are aerosolized, presenting a fine particle fraction, FPF, of at least 30-50% of delivered powder mass, where the entities of the combined doses are delivered either simultaneously or separately in sequence during a single inhalation. An INDEPENDENT CLAIM is also included for a use of different dry powder medicaments, for combination in an inhaler device selecting medicament for a forming of pharmaceutical, combined doses; selecting a pattern of physical positions and extensions in space for separate depositions onto a common doses of metered powder entities constituting the combination of doses; depositing separate, metered powder entities of selected medicaments in the pattern onto the common dose bed, and coordinating the entities of the combination of doses during preparation such that, after having been introduced into an inhaler device adapted for a prolonged delivery, the entities of the different medicament powders, when sucked up become aerosolized and delivered either simultaneously or separately in sequence during a single inhalation.
申请公布号 SE0303128(L) 申请公布日期 2004.12.20
申请号 SE20030003128 申请日期 2003.11.21
申请人 MICRODRUG AG 发明人 NILSSON THOMAS;MYRMAN MATTIAS;FRIBERG CLAES;CALANDER SVEN
分类号 A61J1/00;A61K;A61K9/14;A61K45/06;A61L9/04;A61M15/00;A61P11/06;A61P11/08;(IPC1-7):A61K45/06 主分类号 A61J1/00
代理机构 代理人
主权项
地址